Position in ADMA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$795,745
+$423,668 QoQ
Shares Held
88,318
+333.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bridgefront Capital, LLC holds $16,132,916 across 33 Biotechnology names. ADMA ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
48,362 | $2,319,925 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
12,495 | $1,086,690 | |
| 3 | CGON |
CG Oncology, Inc.
|
14,401 | $974,659 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
34,018 | $810,648 | |
| 5 | ADMA |
Adma Biologics, Inc.
This page
|
88,318 | $795,745 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
35,135 | $736,078 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
7,515 | $730,833 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
31,101 | $726,519 |
All Filings in ADMA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $795,745 | 88,318 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $372,077 | 20,399 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||